Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage

European Journal of Pharmacology

Volumn 379, Issue 1, 1999, Pages 33-45

  Culmsee, Carsten ^a   Stumm, Ralf K ^a   Schäfer, Martin K H ^a   Weihe, Eberhard ^a   Krieglstein, Josef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Astrocyte; b2 Adrenoceptor agonist; Cerebral ischemia, focal; Clenbuterol; FGF fibroblast growth factor, basic; GFAP glial fibrillary acidic protein; NGF nerve growth factor; TGF b1 transforming growth factor b1

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; MESSENGER RNA; NERVE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD PRESSURE; BRAIN ISCHEMIA; CELL ACTIVATION; CONTROLLED STUDY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ASTROCYTES; BLOOD GLUCOSE; BLOOD PRESSURE; BRAIN; CEREBRAL ARTERIES; CEREBRAL CORTEX; CLENBUTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; GLIAL FIBRILLARY ACIDIC PROTEIN; GROWTH SUBSTANCES; HIPPOCAMPUS; IN SITU HYBRIDIZATION; INFARCTION; ISCHEMIA; MALE; RATS; RATS, LONG-EVANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032693550     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00452-5     Document Type: Article

References (70)

1. Anderson K.J., Dam D., Lee S., Cotman C.W. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature. 332:1988;360-361.
2. Angerer, L.M., Stoler, M.H., Angerer, R.C., 1987. In situ hybridization with RNA probes: an annoted recipe. In: Valentino, L., Eberwine, I., Barchas, D. (Eds.), In Situ Hybridization: Applications to Neurobiology. Oxford Univ. Press, New York, p. 42.
3. Arai S., Kinouchi H., Akabane A., Owada Y., Kamii H., Kawase M., Yoshimoto T. Induction of brain-derived neurotrophic factor (BDNF) and the receptor trk B mRNA following middle cerebral artery occlusion in rat. Neurosci. Lett. 211:1996;57-60.
4. Belayev, L., Ginsberg, M.D., Alonso, O.F., Singer, J.T., Kraydieh, S., Busto, R., Kawahara, N., Klatzo, I., 1996. Protective mechanisms in cerebral ischemia: role of transneuronal induction. In: Krieglstein, J. (Ed.), Pharmacology of Cerebral Ischemia 1996. Medpharm Scientific Publishers, Stuttgart, pp. 137-145.
5. Biagini G., Frasoldati A., Fuxe K., Agnati L.F. The concept of astrocyte-kinetic drugs in the treatment of neurodegenerative diseases: evidence for L-deprenyl-induced activation of reactive astrocytes. Neurochem. Int. 25:1994;17-22.
6. Bomont L., MacKenzie E.T. Neuroprotection after focal cerebral ischemia in hyperglycaemic in diabetic rats. Neurosci. Lett. 197:1995;53-56.
7. Carswell S. The potential for treating neurodegenerative disorders with NGF-inducing compounds. Exp. Neurobiol. 124:1993;36-42.
8. Chen H., Chopp M., Schultz L., Bodzin G., Garcia J.H. Sequential neuronal and astrocytic changes after transient middle cerebral artery occlusion in the rat. J. Neurol. Sci. 118:1993;109-116.
9. Choi-Lundberg D.L., Bohn M. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in the rat. Dev. Brain Res. 85:1995;80-88.
10. Culmsee C., Schäfer M.K.H., Schilling M., Weihe E., Krieglstein J. Neuroprotective effect of clenbuterol is accompanied by induction of nerve growth factor mRNA in a model of permanent middle cerebral artery occlusion. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;104. Suppl. 4.
11. Culmsee C., Junker V., Wolz P., Semkova I., Krieglstein J. Lubeluzole protects hippocampal neurons from excitotoxicity in vitro and reduces brain damage caused by ischemia. Eur. J. Pharmacol. 342:1998;193-201.
12. Culmsee, C., Stumm, R.K., Zhu, Y., Semkova, I., Schäfer, M.K.H., Weihe, E., Krieglstein, J., 1998b. Neuroprotection by drug-induced growth factors. In: Krieglstein, J. (Ed.), Pharmacology of Cerebral Ischemia 1998. Medpharm Scientific Publishers, Stuttgart, pp. 333-348.
13. 2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from a NGF-antisense study. Neurochem. Int. 35:1999;47-57.
14. Duverger D., MacKenzie E.T. The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J. Cereb. Blood Flow. Metab. 8:1988;449-461.
15. Finklestein S.P., Kemmou A., Caday C.G. Basic fibroblast growth factor protects cerebrocortical neurons against excitatory amino acid toxicity in vitro. Stroke. 24:1993;I141-I143. Suppl. 1.
16. Finklestein S.P., Meadows M.E., Fisher M., Do T. Intravenous basic fibroblast growth factor reduces infarct size following focal cerebral ischemia in rats. Soc. Neurosci. Abstr. 20:1994;181.
17. Fisher M., Meadows M.E., Do T., Weise J., Trubetskoy V., Charette M., Finklestein S.P. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J. Cereb. Blood Flow. Metab. 15:1995;953-959.
18. Follesa P., Mocchetti I. Regulation of basic fibroblast growth factor and nerve growth factor mRNA by β-adrenergic receptor activation and adrenal steroids in rat central nervous system. Mol. Pharmacol. 43:1993;132-138.
19. Freese A., Finklestein S.P., Difiglia M. Basic fibroblast growth factor protects striatal neurons in vitro from NMDA receptor-mediated excitotoxicity. Brain Res. 575:1992;351-355.
20. Frim D.M., Simpson J., Uhler T.A., Short M.P., Bossi S.R., Breakfield X.O., Isacson O. Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J. Neurosci. Res. 35:1993;452-458.
21. Gao W.Q., Weil R.J., Dugich-Djordjevic M., Lu B. The therapeutic potentials of neurotrophic factors for diseases of the nervous system. Exp. Opin. Ther. Pat. 7:1997;325-338.
22. Hayes V.Y., Isackson P.J., Fabrazzo M., Follesa P., Mocchetti I. Induction of nerve growth factor and basic fibroblast growth factor mRNA following clenbuterol: contrasting anatomical and cellular localization. Exp. Neurol. 132:1995;33-41.
23. Hefti F. Pharmacology of neurotrophic factors. Annu. Rev. Pharmacol. Toxicol. 37:1997;239-267.
24. Hefti F., Hartikka J., Knusel B. Function of neurotrophic factors in the adult and aging brain and their possible use in treatment of neurodegenerative diseases. Neurobiol. Aging. 10:1989;515-533.
25. 1. J. Neural Transm. 43:1994;33-45.
26. 1 protects hippocampal neurons against degeneration caused by transient global ischemia: dose-response relationship and potential neuroprotective mechanism. Stroke. 27:1996;1609-1615.
27. Hodges-Savola C., Rogers S.D., Ghilardi J.R., Timm D.R., Mantyh P. β-Adrenergic receptors regulate astrogliosis and cell proliferation in the central nervous system in vivo. Glia. 17:1996;52-62.
28. Hughes P., Beilharz E., Gluckman P., Dragunov M. Brain-derived neurotrophic factor is induced as an immediate early gene following NMDA receptor activation. Neuroscience. 57:1993;319-328.
29. Iwata A., Masago A., Yamada K. Expression of fibroblast growth factor mRNA after transient focal ischemia: comparison with expression of c-fos, c-jun and hsp 70 mRNA. J. Neurotrauma. 4:1997;201-210.
30. Knuckey N.W., Finch P., Palm D.E., Primiano M.J., Johanson C.E., Flanders K.C., Thompson N.L. Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia. Brain Res. Mol. Brain Res. 40:1996;1-14.
31. Krieglstein, K., Krieglstein, J., 1998. TGF-β signaling and neuroprotection: relevance to ischemic brain injury, Alzheimer's and Parkinson's disease. In: Mattson, M.P. (Ed.), Neuroprotective Signal Transduction. Humana Press, Totowa, pp. 119-144.
32. 1 in brain tissue after ischemic stroke in humans. Stroke. 27:1996;852-857.
33. Lewin G.R., Barde Y.A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19:1996;289-317.
34. Lewin G.R., Ritter A.M., Mendell L.M. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J. Neurosci. 13:1993;1903-1912.
35. Lindsay, R.M., 1996. Neuroprotective action of the neurotrophins and CNTF in vivo. In: Krieglstein, J. (Ed.), Pharmacology of Cerebral Ischemia 1996. Medpharm Scientific Publishers, Stuttgart, pp. 465-475.
36. Lindvall O., Ernfors P., Bengzon J., Kokaia Z., Smith M.L., Siesjö B.K. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc. Natl. Acad. Sci. U.S.A. 89:1992;648-652.
37. Lu B., Yokoyama M., Dreyfus C.F., Black I.B. NGF gene expression in actively growing brain glia. J. Neurosci. 11:1991;318-326.
38. 2-Adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human. J. Neurosci. 15:1995;152-164.
39. Martin, P.M., O'Callaghan, J.P., 1996. Gene expression in astrocytes after neuronal injury. In: Aschner, M., Kimelberg, H.K. (Eds.), The Role of Glia in Neurotoxicity. CRC Press, Boca Raton, FL, pp. 285-310.
40. Mattson M.P., Acheff S.W. Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implication for therapy. J. Neurotrauma. 11:1994;3-33.
41. Melton D.A., Krieg P.A., Rebagliati M.R., Maniatis T., Zinn K., Green M.R. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:1984;7035-7056.
42. Miller R.G., Petajan J.H., Bryan W.W., Armon C., Barohn R.J., Goodpasture J.C. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;256-260.
43. Morrison R.S. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J. Biol. Chem. 266:1991;728-734.
44. Nagai Y., Naruse S., Weiner M.W. Effect of hypoglycemia on changes of brain lactic acid and intracellular pH produced by ischemia. NMR Biomed. 6:1993;1-6.
45. Nieto-Sampedro M., Lewis E.R., Cotman C.W., Manthorpe M., Skaper S.D., Barbin G., Longo F.M., Varon S. Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science. 217:1982;860-861.
46. Osborne K.A., Shigeno T., Balarsky A.M., Ford I., McCulloch J., Teasdale G.M., Graham D.I. Quantitative assessment of early brain damage in a rat model of focal cerebral ischemia. J. Neurol. Neurosurg. Psychiatry. 50:1987;402-410.
47. Pechan P.A., Yoshida T., Panahian N., Moskowitz M.A., Breakefield X.O. Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat. NeuroReport. 6:1995;669-672.
48. Petty B.G., Cornblath D.R., Adornato B.T., Chaudhry V., Flexner C., Wachsmann M., Sinicropi D., Burton L.E., Peroutka S.J. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann. Neurol. 36:1994;244-246.
49. Prehn J.H.M., Peruche B., Unsicker K., Krieglstein J. Isoform-specific effects of transforming growth factors-β on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J. Neurochem. 60:1993;1665-1672.
50. Rudge, R.S., 1993. Astrocyte-derived neurotrophic factors. In: Murphy, S. (Ed.), Astrocytes: Pharmacology and Function. Academic Press, New York, pp. 267-305.
51. Salm A.K., McCarthy K.D. Expression of beta-adrenergic receptors by astrocytes isolated from adult rat cortex. Glia. 2:1989;346-352.
52. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, p. 456.
53. Schäfer M.K.H., Day R., Cullinan D.E., Chretien M., Seidah N.G., Watson S.J. Gene expression of prohormone and proprotein convertases in the rat CNS: a comparative in situ hybridization analysis. J. Neurosci. 13:1993;1258-1279.
54. Schäfer M.K.H., Nohr D., Romeo H., Eiden L.E., Weihe E. Pan-neuronal expression of chromogenin A in rat nervous system. Peptides. 15:1994;263-279.
55. Schroeter M., Schiene K., Kraemer M., Hagemann G., Weigel H., Eysel U.T., Witte O.W., Stoll G. Astroglial responses in photochemically induced focal ischemia of the rat cortex. Exp. Brain Res. 106:1995;1-6.
56. Semkova, I., Culmsee, C., Krieglstein, J., 1996. Neuroprotection caused by NGF and NGF-inducing drugs. In: Krieglstein, J. (Ed.), Pharmacology of Cerebral Ischemia 1996. Stuttgart, Medpharm Scientific Publishers, pp. 477-493.
57. Semkova I., Schilling M., Henrich-Noack P., Rami A., Krieglstein J. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res. 717:1996;44-54.
58. Semkova I., Wolz P., Schilling M., Krieglstein J. Selegilin enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. Eur. J. Pharmacol. 315:1996;19-30.
59. Sendtner M., Schmalbruch H., Stöckli K.A., Caroll P., Kreutzberg G.W., Thoenen H. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motoneuropathies. Nature. 358:1992;502-504.
60. Shao Y., Sutin J. Expression of adrenergic receptors in individual astrocytes and motor neurons isolated from the adult rat brain. Glia. 6:1992;108-117.
61. Shigeno T., Mima T., Takaura K., Graham D.I., Kato G., Hashimoto Y., Furukawa S. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J. Neurosci. 11:1991;2914-2919.
62. Takeda A., Onodera H., Sugimoto A., Kogure K., Obinata M., Shibahara S. Coordinated expression of messenger mRNAs for nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in the rat hippocampus following transient forebrain ischemia. Neuroscience. 55:1993;23-31.
63. 14C ]iodoantipyrine autoradiography following middle cerebral artery occlusion J. Cereb. Blood Flow. Metab. 1:1981;61-68.
64. Walicke P.A. Basic and acidic fibroblast growth factor have trophic effects on neurons from multiple CNS regions. J. Neurosci. 8:1988;2618-2627.
65. 1 exhibits delayed gene expression following focal cerebral ischemia. Brain Res. Bull. 6:1995;607-609.
66. 1 and interleukin-1β mRNA in rat brain following transient forebrain ischemia. Acta Neuropathol. 86:1993;439-446.
67. Williams L.R., Varon S., Peterson G., Wictorin K., Fischer W., Björklund A., Gage F.H. Continuous infusion of nerve growth factor prevents basal forebrain neuronal cell death after fimbria-fornix transection. Proc. Natl. Acad. Sci. U.S.A. 83:1986;9231-9236.
68. Yamashita K., Vogel P., Fritze K., Back T., Hossmann K.A., Wiessner C. Monitoring the temporal and spatial activation pattern of astrocytes in focal cerebral ischemia using in situ hybridization to GFAP mRNA: comparison with sgp-2 and hsp 70 mRNA and the effect of glutamate receptor antagonists. Brain Res. 735:1996;285-297.
69. Yuen E.C., Mobley W.C. Therapeutic potential of neurotrophic factors for neurological diseases. Ann. Neurol. 40:1996;346-354.
70. 2-adrenoceptors inhibits apoptosis in rat brain after transient forebrain ischemia. J. Cereb. Blood Flow Metab. 18:1998;1032-1039.